DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

LinksSchließen

Referenz

Eikelboom JW, O'Donnell M, Yusuf S. et al.
Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment.

Am Heart J 2010;
159 (03) 348-353.e1

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: